BioSpace News Archive

Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provides painless and precise injections, announced that it projects sales for the third quarter ending September 30, 2020 increased sequentially more than five-fold versus the second quarter ending June 30, 2020.

Dr. Runge brings 35 years’ experience as an Emergency Medicine Physician, Federal Government Executive and Public Policy Strategist.

Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy to treat severely calcified cardiovascular disease, announced updated timing for the company’s CAD III Investor Webcast Event to be held in conjunction with TCT Connect.

Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has completed its at-the-market (ATM) offering program initiated during the third quarter, generating gross proceeds of $50.0 million.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced it has completed its tender offer for all outstanding shares of Pfenex Inc. for $437.5 million in cash, plus one non-transferable contingent value right (CVR) per share representing the right to receive a contingent payment of $78 million in cash if a certain specified milestone is achieved

Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acer’s management team will provide a virtual corporate overview at, and participate in, the BIO Investor Forum Digital

Quisitive enables leading ophthalmic lens provider to rollout appointment application to help eye care offices safely reopen around the globe

Imaging Healthcare Specialists has elevated patient experience, care and quality by engaging patients throughout the imaging encounter with Royal Enterprise Care™, a solution tailored to deliver the highest quality imaging workflows available in the industry.

The potential contract value if the three-year extension option is exercised could be up to approximately £3.6 million (or approximately $4.6 million based on the current exchange rate)

VectorCare, a Sausalito-based SaaS company, recently unveiled a major rebranding, reflecting the company’s transformation to an all-in-one patient care logistics solution